Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Curis, Inc. (CRIS)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on CRIS
Newest on CRIS
M. E. Garza
(1)
Ohad Hammer
(1)
Alan Brochstein
(5)
Centient Biotech Investor
(2)
Stockerblog
(1)
Most frequent on CRIS
Alan Brochstein
(
5
)
Centient Biotech Investor
(
2
)
Stockerblog
(
1
)
The Wall Street Analyst Forum
(
1
)
Ohad Hammer
(
1
)
Most followed on CRIS
Alan Brochstein
(
537
)
Stockerblog
(
317
)
Ohad Hammer
(
124
)
M. E. Garza
(
123
)
Centient Biotech Investor
(
7
)
Most commented on CRIS
Alan Brochstein
(
15
)
Stockerblog
(
12
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Curis, Inc. (CRIS)
by
latest
|
most commented
Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
Jul 1
•
M. E. Garza
•
ALLI
,
AHCI
,
ADPI
•
Comment!
|
Quick Read
Spicing Up the Biotech Portfolio with Microcaps CuraGen and Curis
Feb 23
•
Ohad Hammer
•
CRGN
,
CRXL
,
CRIS
•
Comment!
|
Quick Read
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
AFFY
,
AGEN
,
ABPI
•
7 Comments
|
Quick Read
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Biotech Day in Review: Critical Therapeutics Climbs on Co-Promotion Deal
Mar 15, 2007
•
Centient Biotech Investor
•
ADLS
,
ARXT
,
AVGN
•
Comment!
|
Quick Read
Investing in Stem Cell Stocks: Growth Industry of the Future?
Feb 21, 2007
•
Stockerblog
•
ARIA
,
ACTCE
,
ALXN
•
12 Comments
|
Quick Read
Biotech Day In Review: AstraZeneca Enters Two Partnerships Worth $800 Million
Feb 1, 2007
•
Centient Biotech Investor
•
CRIS
,
AVNR
,
AZN
•
Comment!
|
Quick Read